Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (6362)	4/12/1999 12:33:00 AM
From: Linda Kaplan	Respond to of 7041

Bruce: I submit that you don't know why the lawsuit was dismissed and that since neither of us is an attorney, I don't think we can know why without being given some facts. You assume that it was because fraud couldn't be proven. I assume it's because the stock price wasn't low enough. Neither of us knows and it could be a matter of a legal requirement not having been met which has to do with neither issue. SGP was involved in the application for approval in Mexico and obviously had some idea that it would be profitable to go through with it. It was not profitable. You can say they were saving their ammunition for the USA, but then why go ahead with Mexico at all if they weren't going to be fully behind it? I expect they did their best to get sales in Mexico and simply failed. You expect they never tried. If they never tried to get sales, why go through approval, manufacture and distribution efforts? Fact is, Mexico was a FAILURE for Vasomax and I expect that will prove to be prototypical. Linda

To: Bruce Rosen who wrote (6362)	4/12/1999 1:25:00 AM
From: BDR	Read Replies (2) \| Respond to of 7041

<<But to say that since some people on this board speculated that they knew what Schering planned to do in Mexico, your conclusion is that it not happening means there was some kind of failure of Vasomax, strikes me as specious.>> So it is specious to argue that, because Schering got Vasomax approved for sale in Mexico and some amount of product was placed in the distribution pipeline, they were planning to sell it. What are you saying Schering's plan was for Vasomax in Mexico? That Schering deliberately intended to not generate any revenues from sales in Mexico after going to all that trouble? What could possibly be the rationale for that? Sales in Mexico would jeopardize FDA approval? Any sales figure would be construed as low by the short conspiracy and therefore zero sales was much better? I am at a loss to understand your interpretation of events in Mexico.